|
| Press Releases |
|
 |
|
| Thursday, August 28, 2025 |
|
|
Hua Medicine Announces 2025 Interim Results |
| Hua Medicine (the 'Company', HKEx: 2552) announced the unaudited consolidated results of the Company and its subsidiaries for the six months ended June 30, 2025 (the 'Reporting Period'), as well as the Company's business progress during the first half of the year and future outlook. During the Reporting Period, the commercialization of the Company's core product, HuaTangNing'(dorzagliatin tablets), accelerated. The Company's independent operational capabilities improved significantly. more info >> |
|
| Monday, June 23, 2025 |
|
|
Hua Medicine Announces at 2025 ADA Scientific Sessions that Dorzagliatin Combined with DPP-4 Inhibitor Shows Promise in Reducing Blood Lipids While Restoring Glucose Homeostasis |
| Hua Medicine ("the Company", stock code: 2552.HK) announced today that the Company presented the latest research results of dorzagliatin, its global first-in-class glucokinase activator (GKA), at the 85th Scientific Sessions of the American Diabetes Association (ADA). more info >> |
|
| Friday, March 28, 2025 |
|
|
Hua Medicine Announces 2024 Annual Results |
| Hua Medicine ("the Company", Hong Kong Stock Exchange Stock Code: 2552) announced the audited full-year results of the Company and its subsidiaries for the year ended December 31, 2024 (the "Reporting Period"), along with the Company's business progress in 2024 and future business outlook. more info >> |
|
| Tuesday, March 18, 2025 |
|
|
Dr. Li Chen Honored as A Leading Figure in Shanghai's Industry and Commerce |
| On March 17th, the highly anticipated 7th Commendation and Exchange Conference for the Leading Figures in Shanghai's Industry and Commerce was brought to a successful conclusion. Dr. Li Chen, the founder and CEO of Hua Medicine, was awarded the title of "A Leading Figure in Shanghai's Industry and Commerce" for his outstanding contributions and innovative leadership in the field of biomedicine. more info >> |
|
| Monday, March 3, 2025 |
|
|
Hua Medicine Awarded Shanghai Innovative Enterprise Headquarters |
| On February 27th, the awarding ceremony of the second batch of Shanghai Innovative Enterprise Headquarters was held in Shanghai. Gong Zheng, Deputy Secretary of Shanghai Municipal Party Committee and Mayor of Shanghai, awarded the certificates to 49 innovative enterprise headquarters, and Hua Medicine was among them. more info >> |
|
| Saturday, November 30, 2024 |
|
|
Hua Medicine Announces Successful U.S. Phase I Results on Its 2nd Generation GKA Candidate |
| Hua Medicine (the 'Company', HKEx stock code: 2552) announced today that the Company has successfully completed a Phase I clinical trial on its 2nd generation GKA candidate in U.S. at the 9th China BioMed Innovation and Investment Conference (CBIIC). more info >> |
|
|
Hua Medicine Announces Successful H.K. SENSITIZE Study Results at the CBIIC |
| Hua Medicine (the 'Company', HKEx stock code: 2552) announced today that the Company has successfully completed its SENSITIZE study on the mechanism by which dorzagliatin improves the β-cell glucose sensitivity at the 9th China BioMed Innovation and Investment Conference (CBIIC). more info >> |
|
| Friday, October 25, 2024 |
|
|
Founder of Hua Medicine Dr. Chen Li was awarded the 'C.C. Tan Life Science Industrialization Award' |
| The 17th C.C. Tan Life Science Award ceremony was held at Shenyang Pharmaceutical University on October 9th. Dr. Chen Li, Founder and Chief Executive Officer of Hua Medicine, was awarded the C.C. Tan Life Science Industrialization Award . more info >> |
|
| Friday, August 30, 2024 |
|
|
Hua Medicine Announces 2024 Interim Results |
| Hua Medicine (the "Company", HKEx: 2552) today announces the unaudited consolidated results of the Company and its subsidiaries for the six months ended June 30, 2024 (the "Reporting Period"), and the Company's business progress for the first half of the year and business outlook. more info >> |
|
| Friday, August 25, 2023 |
|
|
Hua Medicine Announces 2023 Interim Results |
| First-in-class glucokinase activator (GKA) HuaTangNing (dorzagliatin) was approved in China in September 2022. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
Mitsubishi Motors Launches the All-New Eclipse Cross Electric Vehicle for the European Market
Sept 18, 2025 0:58 JST
|
|
|
Mitsubishi Motors to Begin Sales of All-New Delica Mini and eK Space in Japan in October
Sept 18, 2025 0:50 JST
|
|
|
Upgraded GR Corolla Set for Japan Launch
Sept 18, 2025 0:48 JST
|
|
|
Honda Koraidon Ride on Experience and Onboard Showrun to be Held at Honda Collection Hall
Sept 18, 2025 0:42 JST
|
|
|
Mitsubishi Motors Increases Investment Stake in Australian Automotive Financial Services Company to 19.93%
Sept 18, 2025 0:27 JST
|
|
|
MHI Is Awarded Contract for 20 Units of the Outer Vertical Target for the Divertor Used in the ITER in Southern France
Sept 18, 2025 0:16 JST
|
|
|
NTT and Mitsubishi Heavy Industries Achieved World's Highest Efficiency in Laser Wireless Power Transmission under Atmospheric Turbulence
Sept 18, 2025 0:00 JST
|
|
|
Galaxy Payroll Group Limited Granted Additional 180-Day Compliance Period by Nasdaq to Regain Minimum Bid Price Requirement
Sept 18, 2025 22:30 HKT/SGT
|
|
|
CGSI Reiterates 'Add' Rating on Modern Dental (03600.HK) with Raised Target Price of HK$6.88
Sept 18, 2025 16:30 HKT/SGT
|
|
|
Counterfeit Products Sold Online in Malaysia Threaten Halal Compliance, Consumer Health, and the E-Commerce Sector, Says Muslim Consumers Association (PPIM)
Sept 18, 2025 13:20 HKT/SGT
|
|
|
Dongwu Cement (00695.HK) Undergoes Major Transformation with Suzhou State Capital Takeover
Sept 18, 2025 08:30 HKT/SGT
|
|
|
GMG Launches First to Market Multi Language Global Graphene Enhanced Product Range for Distributors
Sept 17, 2025 19:39 HKT/SGT
|
|
|
Casa Minerals Inc Announces Advanced Ground IP Survey at the Arsenault Project
Sept 17, 2025 18:09 HKT/SGT
|
|
|
Definitive agreement to implement a joint mine plan between Los Bronces and Andina copper mines
Sept 17, 2025 18:57 JST
|
|
|
Open Doors to the Asian Market: Seoul Bio Hub-Celltrion Launches 'Global Open Innovation' for U.S. Startups 
Sept 17, 2025 17:30 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
